— Know what they know.
Not Investment Advice

OMER NASDAQ

Omeros Corporation
1W: -9.9% 1M: -10.6% 3M: -0.7% YTD: -27.0% 1Y: +263.5% 3Y: +124.8% 5Y: -34.3%
$11.46
-0.50 (-4.18%)
 
Weekly Expected Move ±8.0%
$10 $11 $12 $13 $14
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 35 · $829.4M mcap · 70M float · 1.68% daily turnover · Short 64% of daily vol

Cash Flow Trends

Operating Cash Flow
-$149M -299.1% ▼
Capital Expenditures
$165K +61.3% ▲
5Y CAGR: -13.2%
Free Cash Flow
-$149M -300.5% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$12M -154.6% ▼
Net Change in Cash
-$4M +5.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$138M-$192M-$182M-$118M-$157M
Depreciation & Amort.$2M$1M$952K$920K$950K
Stock-Based Comp.$15M$0$0$12M$10M
Change in Working Capital$8M-$14M-$119M$247M$30M
Other Non-Cash Items$26M$95M$214M-$67M-$33M
Operating Cash Flow-$100M-$110M-$86M$75M-$149M
— Investing Activities —
Capital Expenditures-$283K-$277K-$113K-$426K-$165K
Acquisitions (Net)$0$126M$0$0$0
Investment Purchases-$133M-$32M-$429M-$1.0B-$987M
Investment Sales$66M$100M$302M$1.0B$1.1B
Other Investing$0$0$0$0$0
Investing Cash Flow-$67M$194M-$128M$27M$82M
— Financing Activities —
Net Debt Issuance$98M-$2M$124M-$102M-$41M
Stock Repurchased$0$0$0-$5M-$12M
Dividends Paid$0$0$0$0$0
Other Financing-$17M-$241K$0$150K$116M
Financing Cash Flow$175M$6M$124M-$106M$63M
Net Change in Cash$7M$90M-$90M-$4M-$4M
Cash End of Period$11M$101M$11M$7M$3M
Free Cash Flow-$100M-$110M-$87M$74M-$149M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms